Growth Metrics

SELLAS Life Sciences Group (SLS) Share-based Compensation: 2011-2024

Historic Share-based Compensation for SELLAS Life Sciences Group (SLS) over the last 7 years, with Sep 2024 value amounting to $381,000.

  • SELLAS Life Sciences Group's Share-based Compensation fell 29.83% to $381,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $1.7 million, marking a year-over-year decrease of 17.38%. This contributed to the annual value of $1.6 million for FY2024, which is 25.31% down from last year.
  • Latest data reveals that SELLAS Life Sciences Group reported Share-based Compensation of $381,000 as of Q3 2024, which was up 14.07% from $334,000 recorded in Q2 2024.
  • In the past 5 years, SELLAS Life Sciences Group's Share-based Compensation registered a high of $543,000 during Q3 2023, and its lowest value of $141,000 during Q4 2020.
  • In the last 3 years, SELLAS Life Sciences Group's Share-based Compensation had a median value of $455,000 in 2022 and averaged $455,545.
  • As far as peak fluctuations go, SELLAS Life Sciences Group's Share-based Compensation surged by 104.26% in 2021, and later crashed by 35.02% in 2024.
  • Quarterly analysis of 5 years shows SELLAS Life Sciences Group's Share-based Compensation stood at $141,000 in 2020, then spiked by 104.26% to $288,000 in 2021, then soared by 54.86% to $446,000 in 2022, then climbed by 11.43% to $497,000 in 2023, then decreased by 29.83% to $381,000 in 2024.
  • Its Share-based Compensation stands at $381,000 for Q3 2024, versus $334,000 for Q2 2024 and $476,000 for Q1 2024.